Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation by unknown
DEPOSITION  OF  IDIOTYPE-ANTI-IDIOTYPE 
IMMUNE  COMPLEXES  IN  RENAL  GLOMERULI 
AFTER  POLYCLONAL  B  CELL  ACTIVATION* 
BY MICHEL GOLDMAN,~ LYNN  MASSMAN  ROSE, AGNES  HOCHMANN, 
AND PAUL HENRI  LAMBERT§ 
From the World  Health Organization Immunology Research and Training Centre, Centre of Transfusion and 
Department of Medicine, HGpital Cantonal, Geneva, Switzerland 
Immune complexes (IC) 1 are thought to play a  major role in the pathogenesis of 
many human glomerulonephritides (1). This has been suggested by immunofluores- 
cence studies showing glomerular deposits of immunoglobulins and complement and 
by observations of electron-dense deposits around or within the glomerular basement 
membrane. In addition, glomerulonephritides are a common feature of some autoim- 
mune or infectious diseases associated with the persistence of IC in the circulation (2, 
3).  Many  attempts  have  been  made  to  identify  the  antigenic  components  of the 
circulating and glomerular IC detected in these diseases. However, in most cases, the 
nature of the involved antigens remains largely unknown (4). 
Polyclonal hypergammaglobulinemia  is  a  frequent  finding in  IC  diseases  (5-9). 
This has led to thinking that polyclonal B cell hyperactivity could be involved in the 
generation of IC.  Experimentally, polyclonal B  cell activation  induced in  mice by 
bacterial lipopolysaccharides (LPS) or other B cell mitogens has been shown to be 
associated with the occurrence of both circulating and glomerular IC  (10,  11). The 
mechanisms of this association have not been well defined. As activation of the B cell 
compartment  induces  the  production  of various  auto-antibodies,  including  anti- 
immunoglobulin antibodies (12), some of the complexes might result from the reaction 
of anti-immunoglobulin antibodies with other immunoglobulin molecules. Idiotypes 
and  corresponding anti-idiotypic auto-antibodies  are potential candidates  for such 
immunoglobulin interactions within the B cell repertoire (13). Recently, we were able 
to demonstrate the simultaneous production of immunoglobulins bearing a  known 
idiotype, the TEPC- 15 (T 15) idiotype, of corresponding anti-idiotypic antibodies and 
of circulating T 15 idiotype-anti-T 15-idiotype IC in BALB/c mice injected with LPS  2 
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or  infected  with  trypanosomes  (14).  The  T15  idiotype  is  the  major  idiotype  of 
BALB/c  mouse anti-phosphorylcholine (PC)  antibodies  (15). The cross-reactivity of 
this  idiotype  with  the  idiotype  of the  TEPC-15  myeloma  protein  facilitates  the 
detection  of anti-T15  idiotype auto-antibodies  and  the preparation  of heterologous 
anti-T15  idiotype antibodies  that  are  used  to detect  immunoglobulins  bearing T15 
idiotypic determinants  (16). 
In this report, we investigated whether T15 idiotype-anti-T15 idiotype IC could be 
involved in the glomerular lesions observed in BALB/c mice injected with LPS. The 
presence in the kidneys of IC reacting with TEPC-15 myeloma protein or with rabbit 
anti-Tl5  idiotype antibodies was investigated  in immunofluorescence studies and in 
trace-labeling  experiments.  In  addition,  kidney-deposited  immunoglobulins  were 
eluted, radiolabeled, and analyzed by solid-phase radioimmunoassay for the presence 
of T 15 idiotype-bearing molecules and of anti-T 15 idiotype antibodies. 
Materials  and Methods 
Mice.  6- to 8-wk-old female BALB/c mice were purchased from IFFA CREDO (Centre de 
Recherche et d'Elevage des Oncins, St. Germain-sur-l'Arbresle, France). 
LPS.  LPS W of Salmonella typhimurium (lot 657763) were obtained from Difco Laboratories, 
Detroit, MI. LPS preparations were diluted to the concentration of 250/~g/ml and were injected 
intraperitoneally in a final volume of 0.2 ml. 
Monoclonal Antibodies.  The TEPC-15, MOPC-167, and MOPC-460 myeloma proteins were 
purified by affinity chromatography from the ascites  fluid of BALB/c mice transplanted with 
the  corresponding  plasmocytoma  (17) obtained  from  Dr.  M.  Potter  (National  Institute  of 
Health,  Bethesda,  MD),  as  previously described  (18, 19). Briefly,  the  PC-binding  IgA (K) 
TEPC-15 and MOPC-167 were specifically eluted from a Sepharose glyeyltyrosine PC column, 
and  the  dinitrophenyl  (DNP)-binding IgA  (K)  MOPC-460  were  eluted  from  a  Sepharose 
E-N-DNP lysine column. T 15 idiotype-positive IgM monoclonal antibody and HPC- 16, another 
monoclonal anti-PC IgM antibody produced by cell hydidization, were a kind gift from Dr. H. 
Cosenza (Department of Microbiology, University Nationale, Honduras). Mouse IgG myeloma 
proteins were purchased from Litton Bionetics,  Kensington, MD. 
Antigens.  DNP- and PC-bovine serum albumin (BSA) conjugates were prepared according 
to the method of Claflin et al.  (15). 
Radiolabeling Procedures.  TEPC-15 myeloma protein, MOPC-167 myeloma protein, PC-BSA, 
and DNP-BSA were radiolabeled with [12~I]Na (Radiochemical Centre, Amersham, England) 
by the chloramine-T method (20). In all cases, the specific activity was ~  1 ftC/ftg. For dual- 
labeling experiments, MOPC-167 was labeled with [13aI]Na, specific  activity being 0.2 pC/pg. 
Staphylococcal protein  A  (Pharmacia  Fine Chemicals,  Uppsala,  Sweden)  was labeled  with 
[12SI]Na, according to Bolton and Hunter (21). 
Fluorescein Isothiocyanate (FITC) Conjugates.  FITC-eonjugated rabbit anti-mouse IgG, rabbit 
anti-mouse IgM, rabbit anti-mouse C3, and goat anti-rabbit IgG antisera were purchased from 
Nordic Laboratories, Tilburg, the Netherlands.  FITC-conjugated goat anti-rabbit IgG antise- 
rum was adsorbed on a Sepharose mouse IgG column before use. TEPC-15 and MOPC-167 
myeloma proteins were conjugated with FITC (Baltimore Biological Laboratories, Cockeysville, 
MD), according to the method of Kawamura (22). Fluorochrome to protein ratio was between 
2 and 3. 
Preparation and Purification of the Rabbit Anti-TEPC-15 Myeloma Protein Antibodies.  Three rabbits 
were immunized with  1 mg of TEPC-15 myeloma protein ~.n complete Freund's adjuvant and 
1 mo later with  1 mg of TEPC-15 myeloma protein  in  incomplete Freund's adjuvant.  The 
rabbits were bled weekly, and the injection and bleeding schedule were repeated 2 mo later. 
IgG fraction of rabbit anti-TEPC-15 myeloma protein antisera was obtained by precipitation 
in 50% ammonium sulfate, followed by diethylaminoethyl (DEAE)-cellulose column chroma- 
tography (Whatman DE 23, Whatman Reeve Angel, Clifton, N  J) in 0.01 M phosphate buffer, 
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bromide-activated Sepharose 4B  (Pharmacia Fine Chemicals, Uppsala, Sweden)  coupled to 
normal BALB/c serum proteins according to Cuatrecasas (23) and, in addition, by adsorption 
on MOPC-460 and MOPC-167-Sepharose immunosorbents. 
Idiotypic Specificity of the Purified Anti-TEPC-15 Myeloma Protein Antibodies.  The specificity of 
the adsorbed IgG fraction for the T15 idiotype was assessed in a solid-phase radioimmunoassay. 
Polystyrene microtiter tubes (Cooke Laboratory Products, Alexandra, VA) were coated with 
100/xl of serial dilutions of TEPC-15  myeloma protein or MOPC-167  myeloma protein in 
carbonate buffer (0.05  M, pH 9.6)  for 3 h  at 37°C. The tubes were washed three times with 
borate-buffered saline (BBS)-Tween  (Tween  20,  0.025%).  To the empty tubes,  100 #1 of the 
rabbit anti-TEPC-15  myeloma protein IgG fraction (100 #g/ml)  was added and allowed to 
incubate 3 h at room temperature. Each test was performed in duplicate. As control, tubes were 
incubated with IgG purified from normal rabbit sera. After this incubation, the tubes were 
washed three times with BBS-Tween, and  100 #1 of [l~5I]protein A  (0.5 #g/ml) was added to 
each tube and left to incubate overnight at 4°C. Finally, the tubes were washed and counted. 
As shown in Fig.  1, the rabbit anti-TEPC-15 myeloma protein IgG fraction reacted with the 
TEPC-15  myeloma protein but not with the MOPC-167  myeloma protein, another anti-PC 
IgA (K) that does not bear the TEPC-15 idiotype (24). 
The idiotypic specificity of the anti-TEPC-15 myeloma protein antibodies was also tested by 
an indirect fluorescent antibody technique on plasmacytoma imprints. TEPC-15, MOPC-460, 
and MOPC-167 plasmacytoma imprints were fixed in acetone, washed in phosphate-buffered 
saline (PBS), and incubated with the anti-TEPC-15 myeloma protein antibodies for 30 rain. 
After three washings in PBS, an FITC-conjugated goat anti-rabbit IgG antiserum was applied 
for 30 min. Finally, the slides were washed and viewed under a Leitz Orthoplan microscope (E. 
Leitz, Inc., Rockleigh, N  J). TEPC-15  plasma cells were strongly stained, whereas no staining 
was obtained on MOPC-460 nor on MOPC-167 plasma cells (Fig. 2). 
Detection of Circulating IC by an Amplified  Conglutinin-binding Test.  IC were detected by the 
conglutinin-binding test  (25),  as modified by Barnet et al. (26).  Briefly, serum samples were 
incubated  in  microtiter  polystyrene tubes  that  had  been  precoated  with  purified  bovine 
conglutinin (27),  allowing IC that carry C3bi to react with the solid-phase conglutinin. The 
conglutinin-bound complexes were  then  incubated with a  goat anti-mouse IgM antiserum. 
Finally, the  complexes were  quantitated  by measuring  the  binding of added  radiolabeled 
[t2SI]protein A. The results are expressed as bound [x25I]protein A  (cpm). 
Detection of  Specific Idiotype-Anti-Idiotype IC in the Circulation.  The presence of anti-T 15 idiotype 
antibodies  in  circulating IC  was  investigated  in  a  two-step  conglutinin-binding assay,  as 
previously described (14).  Conglutinin-bound IC were incubated with an excess of idiotype 
provided by [12SI]TEPC-15 myeloma protein, and the binding of this protein was measured as 
an indication of the amount of free anti-T15 idiotype antibody within the complexes. To test 
the idiotypic specificity of this binding, conglutinin-bound complexes were also incubated with 
[125I]MOPC-167,  a  monoclonal anti-PC antibody that  does not bear the TEPC-15  idiotype. 
The results are expressed as bound 125I-labeled protein (cpm). 
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Fro.  t.  Radioimmunological  analysis of the  idiotypic  specificity  of the  rabbit  anti-TEPC-15 
myeloma protein  antibodies.  Anti-TEPC  15 myeloma protein  activity (0)  and anti-MOPC  167 
myeloma protein activity (©) of the rabbit antibodies are expressed as percent [a2~I]protein  A bound 
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Flo.  2.  Immunofluorescence  analysis  of the  idiotypic  specificity  of the  rabbit  anti-TEPC-15 
myeloma protein antibodies. Left,  staining of TEPC  15 plasma cells. Right, lack of staining of 
MOPC 167 plasma cells, × 600. 
Detection of lgG, IgM,  C3, and T15 Idiotypic Determinants in Renal Glomeruli.  Renal specimens 
were immediately snap-frozen and stored in liquid nitrogen until used. Frozen sections were cut 
at  3-4/xm, washed  in PBS, and fixed at  4°C  in alcohol-ether (1:1). The fixed sections were 
incubated with one of the  following FITC conjugates: rabbit  anti-mouse IgG,  rabbit  anti- 
mouse IgM, and rabbit anti-mouse C3. After washing in PBS, the slides were viewed under a 
Leitz Orthoplan microscope. Renal deposits of T 15 idiotypic determinants were detected by an 
indirect immunofluorescence technique. Fixed sections were  incubated with  the rabbit anti- 
T15  idiotype IgG fraction for 40 rain. After three washings in PBS, a  fluorescent goat  anti- 
rabbit  IgG  antiserum was  applied  for  30  min,  then  the  slides  were  washed  and  mounted. 
Control experiments included incubation with normal rabbit IgG instead of rabbit anti-T15 
idiotype IgG fraction. 
Kidney Studies after Intravenous Injection of Myeloma Proteins.  In a first series of experiments, mice 
were injected intravenously with either 800/~g of FITC-conjugated TEPC-15 myeloma protein 
or 800 p,g of FITC-conjugated MOPC-167 myeloma protein.  1 h after the injection, mice were 
killed, and kidneys were immediately snap-frozen in liquid nitrogen. Frozen sections were then 
examined for  the presence of FITC conjugate.  In another group  of mice,  the specific renal 
localization of TEPC-15 myeloma protein after in vivo injection was investigated in a  trace- 
labeling experiment. Mice were injected intravenously with  15/ag of [t25I]TEPC-15 myeloma 
protein and 15 gg of [131I]MOPC-167 myeloma protein in a total volume of 0.3 ml. 1 h after the 
injection, animals were  killed  by exsanguination from  the  retro-orbital  plexus  under ether 
anesthesia.  Kidneys were  minced in PBS, washed  five times to  remove blood, weighed,  and 
counted in a  Biogamma counter (Beckman Instruments Inc., FuUerton, CA).  100/tl of serum 
was  counted  simultaneously. The  specific  renal  localization of [I2SI]TEPC-15  myeloma,  as 
compared with that of [lalI]MOPC-167 myeloma protein, was calculated as follows (28): 
renal [~alI]MOPC-167  x serum [125I]TEPC-15 
specific renal [125I]TEPC-15  = renal [a2SI]TEPC-15 
serum [t31I]  MOPC-  167 
Statistical significance was determined by the Wilcoxon's rank sum test. 
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TABLE I 
Presence of Anti-Tl5 Idiotype Antibodies in Circulating IC after Injection of LPS in BALB/c Mice 
Days after LPS injection* 
0  3-6  9  12  15-18  21-28 
Conglutinin-binding IC*  116.9 ±  (37.9)  400,2 ±  (175,9)  419.8 ±  (77.9)  2447 4- (87,0)  231.4 ±  (708) 
Binding of added  [Iz~I]TEPC 15  219.4 -*- (143.1)  365.4 4- (103,1)  527.3 ±  (935)  428.4 ±  (87.0)  468.0 ±  (169.5) 
idiotype to IC§  [I~I]MOPC  167  245.3 ±  (109.2)  273.0 ±  (200.7)  207.0 4- (96.1)  247.6 4- (121.4)  193.0 4- (40,8) 
* Counts per minute bound  [lZ~l]protein  A (mean ±  SD). 
:~ 10 mice were bled at each time of investigation. 
§ Counts per minute bound [12Sl]myeloma  protein (mean ±  SD). 
and eluated according to the method of Lambert and Dixon (29). Briefly, kidneys were minced 
and washed five times in PBS and then homogeneized in an "omnimixer" for 2 min at medium 
speed.  The suspension was centrifuged at 3,500 g for 15 min and washed three times in PBS at 
4°C. The washed sediment was suspended in 0.02 M  citrate buffer, pH 3.2, and incubated at 
37°C for 90 rain. The suspension was brought back to 4°C and the molarity to 0.15 M  NaC1. 
After a eentrifugation at 3,500 g for 15 rain, the supernatant was extensively dialyzed against 
PBS.  The globulin  fraction was obtained  by precipitation  in  50%  ammonium  sulfate.  The 
eluates were studied by double immunodiffusion and immunoelectrophoresis. The amount of 
IgG and IgM was estimated by radial immunodiffusion in agar using rabbit anti-mouse IgG 
and rabbit anti-mouse IgM antisera  (Nordic Laboratories)  (30). The globulin fraction of the 
eluates was labeled with [125I]Na  by the chloramine-T method, specific activity being 1 #C/pg. 
The presence in the radiolabeled eluates of immunoglobulins bearing T15 idiotypic determi- 
nants and of anti-T15 idiotype antibodies was investigated by solid-phase radioimmunoassay. 
Polystyrene microtiter tubes were coated with  100 pl of serial  dilutions of TEPC-15 myeloma 
protein or rabbit anti-T15 idiotype IgG fraction in carbonate buffer (0.05 M pH 9.6) for 3 h at 
37°C.  The tubes were washed  three  times with  BBS-Tween.  To empty tubes,  100/~1 of the 
radiolabeled  eluates  diluted  1:15  in BBS was added  and allowed  to incubate  4  h  at  room 
temperature.  Each  test  was  performed  in  duplicate.  After  this  incubation,  the  tubes  were 
washed three times and counted. Control experiments were done by incubating the radiolabeled 
eluates  in  tubes  coated  with  HPC-16  antibody,  MOPC-460  myeloma protein,  and  control 
•  -  125  rabbit  IgG. The coating of the tubes  was assessed  by incubation wlth  [  I]PC-BSA for the 
125  tubes coated with TEPC-15 myeloma protein or HPC-16 antibody, with  [  I]DNP-BSA for 
the  tubes  coated with  MOPC-460  myeloma protein,  and  with  [12SI]protein A  for the  tubes 
coated with rabbit anti-TEPC-15 antibodies or control rabbit IgG. 
Results 
Detection  of  Circulating  T15  Idiotype-Anti-T15-Idiotype  IC  after  Injection  of  Bacterial 
LPS.  Confirming  previous  experiments, 2  we  detected  circulating  IC  after  LPS 
injection and were able to demonstrate that some of these complexes contained anti- 
T15  idiotype antibodies.  Indeed,  conglutinin-bound  complexes reacted  significantly 
with [125I]TEPC-15 myeloma protein but not with [x25I]MOPC-167 myeloma protein, 
another PC-binding IgA (K)  that does not bear the TEPC-15 idiotype (Table I). 
Detection  of  T15  Idiotypic  Determinants  in  Glomerular IC  after  Injection of Bacterial 
LPS.  Kidneys were first  studied  by direct  immunofluorescence for the presence of 
immunoglobulins and complement 0, 6,  12,  18, and 28 d  after LPS injection. Diffuse 
and granular deposits of IgG and IgM were found after LPS administration  (Fig. 3) 
in the mesangial areas as well as along the glomerular capillary walls. Similar deposits 
of C3 were found in all examined mice from day 12 to day 28. Using a specific indirect 
immunofluorescence  technique,  we  investigated  whether  rabbit  anti-T15  idiotype 
antibodies  could  detect  free  T15  idiotypic  sites  within  the  IC  deposited  in  the 1390  RENAL  DEPOSITION  OF  IDIOTYPE-ANTI-IDIOTYPE  COMPLEXES 
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F,o.  3.  Kinetics of the glomerular deposition of IgG  (0),  IgM  (A),  and T15  idiotype-bearing 
immunoglobulins (O) after LPS injection. Each point represents the percentage of mice showing 
glomerular deposits detected by immunofluorescence (five mice in each examination). 
glomeruli. From day 6 to day 28 after LPS injection, 13 out of 20 mice showed focal 
and granular deposits of molecules reacting with the rabbit anti-T15-idiotype anti- 
bodies  (Fig.  3)  along glomerular capillary walls and  in  mesangial areas  (Fig.  4 a). 
When the slides were incubated with normal rabbit IgG instead of the anti-idiotypic 
antibodies, no glomerular staining was found. The idiotypic specificity of the deposits 
was further assessed  in inhibition experiments, where the slides were incubated with 
an excess (1 mg/ml) of the TEPC-15 myeloma protein or of the T15 idiotype-positive 
IgM monoclonal antibody in addition to the anti-TEPC-15 idiotype antibodies. The 
addition of T 15 idiotype resulted in a marked inhibition of the glomerular binding of 
the  anti-idiotypic antibodies  (Fig.  4b).  In  contrast,  glomerular  staining  was  still 
observed when MOPC-460  myeloma protein was added to the anti-idiotypic anti- 
bodies. 
Glomerular Localization of FITC-conjugated  TEPC-15 Myeloma Protein after Intravenous 
Injection.  The presence in the glomerular IC of anti-T15 idiotype antibodies could 
not be investigated by conventional in vitro immunofluorescence methods because of 
unavoidable background  staining.  Therefore,  attempts were  made  to  detect  these 
antibodies using an in vivo staining procedure. In these experiments, FITC-conjugated 
TEPC-15 myeloma protein was injected intravenously in mice that had been injected 
18 d earlier with LPS. Examination of kidney sections after injection of the fluorescent 
TEPC-15  myeloma protein revealed fine, focal, and granular deposits in mesangial 
areas and along some glomerular capillary walls in five out of seven mice (Fig.  5 a). 
No glomerular staining was found in five control mice injected with FITC-conjugated 
TEPC-15  myeloma protein.  To  assess  the  idiotypic specificity of the  glomerular 
binding of the injected TEPC-15  myeloma protein,  similar experiments were per- 
formed using FITC-conjugated MOPC-167  myeloma protein, another anti-PC IgA 
(K) that does not bear the TEPC-15 myeloma idiotype. No glomerular staining was 
detected after intravenous injection of this myeloma protein in five mice previously 
injected with LPS (Fig. 5 b). 
Radioisotopic Evaluation  of the  Renal  Localization  of  TEPC-15  Myeloma Protein after 
Intravenous Injection.  These  experiments  were  performed  to  obtain  a  quantitative 
confirmation of the specific renal localization of TEPC-15 myeloma protein after in M.  GOLDMAN,  L.  M.  ROSE,  A.  HOCHMANN,  AND  P.  H.  LAMBERT  1391 
Fro.  4.  (A)  Glomerular deposits of T15  idiotype-bearing immunoglobulins detected by indirect 
immunofluorescence  12  d  after  LPS  injection, X 600.  (B)  Inhibition  of glomerular  staining  by 
incubation with an excess of T15  idiotype in addition to the rabbit anti-Tl5  idiotype antibodies, 
x 600. 1392  RENAL  DEPOSITION  OF  IDIOTYPE-ANTI-IDIOTYPE  COMPLEXES 
FxG.  5.  (A) Glomerulus after in vivo injection of FITC-conjugated TEPC-15 myeloma protein in 
a mouse injected 18 d earlier with LPS, ×  600. (B) Idem, after in vivo injection of FITC-conjugated 
MOPC-167 myeloma protein, ×  600. M.  GOLDMAN,  L.  M.  ROSE,  A.  HOCHMANN,  AND  P.  H.  LAMBERT  1393 
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FIG.  7.  ldiotypic analysis of the radiolabeled kidney eluates by solid-phase radioimmunoassay. 
Results are expressed as cpm (10 -2) bound []2hi]kidney  eluates. (A) Reaction with anti-Tl5 idiotype 
antibodies (0) and with control rabbit antibodies (C)). (B) reaction with TEPC-15 myeloma protein 
(O), HPC-16 antibody (O), and MOPC 460 myeloma protein (A). 
vivo injection. Equal amounts of [12SI]TEPC-15  myeloma protein and [131I]MOPC- 
167  myeloma protein  were  injected simultaneously, either  in  mice that  had  been 
injected previously with LPS or in control mice. The specific renal  localization of 
[z25I]TEPC-15  myeloma protein was evaluated by comparison with the renal locali- 
zation of [131I]MOPC-167  myeloma protein. As shown in Fig. 6, the idiotype-specific 
renal localization of [x25I]TEPC-15  myeloma protein was significantly higher in mice 
that had been previously injected with LPS (P <  0.01). 
Idiotypic Analysis of the Immunoglobulins Eluted from Kidneys.  The kidney eluates were 
shown by double immunodiffusion and by electrophoretic analysis to contain mouse 
immunoglobulins but no other mouse serum proteins• The amounts of IgG and IgM 
estimated by radial immunodiffusion were, respectively, 2.3 and 0.6 ~g/g of kidney. 
After radiolabeling, the kidney eluates were investigated by solid-phase radioim- 
munoassay for the presence of immunoglobulins bearing TI5 idiotypic determinants 
and  anti-T15  idiotype  antibodies•  First,  immunoglobulins  bearing  T15  idiotypic 
determinants were detected by incubating the [x25I]eluates in tubes coated with rabbit 
anti-T15 idiotype antibodies. As shown in Fig.  7a, a  significant binding was found 
that  was not detected when  the  [125I]eluates were incubated  in  tubes coated with 1394  RENAL  DEPOSITION OF  IDIOTYPE-ANTI-IDIOTYPE COMPLEXES 
control rabbit IgG. Second, the presence of anti-T15 idiotype antibodies was investi- 
gated by incubating the eluates in tubes coated with TEPC-15 myeloma protein. As 
shown in Fig. 7b, the [a25I]eluates reacted with TEPC-15 myeloma protein but not 
with two other immunoglobulins that do not bear the TEPC-15  idiotype (HPC-16 
antibody and  MOPC-460  myeloma protein).  To  ascertain  that  immunoglobulins 
were responsible for the reaction of the radiolabeled eluates with TEPC-15 myeloma 
protein and with rabbit anti-T15 idiotype antibodies, the radioimmunoassays were 
repeated after adsorption of the [12SI]eluates on Sepharose 4B coupled to anti-mouse 
immunoglobulin antibodies. 96% of the binding to TEPC-15 myeloma protein and 
98% of the binding to anti-T15 idiotype antibodies was eliminated by this procedure. 
These experiments allowed us to estimate at 4-5% the proportion of immunoglobulins 
eluted from kidneys bearing T15 idiotypic determinants. The estimated amount of 
anti-T15 idiotype antibodies was similar. 
Discussion 
A single injection of bacterial LPS in mice has been previously shown (10) to induce 
glomerular lesions associated with other features of systemic lupus erythematosus, 
such as the production of anti-DNA antibodies and circulating IC. The glomeruli 
showed only minimum histologic alterations, but electron microscopy demonstrated 
electron-dense deposits within the glomerular basement membrane, and immunoflu- 
orescence studies showed glomerular deposits of immunoglobulins and complement, 
suggesting the presence of IC. As LPS injection was followed by (a)  release of free 
DNA in the circulation and (b) polyclonal B cell activation with production of anti- 
DNA antibodies (31), a possible involvement of DNA-anti-DNA has been considered. 
A  model of in situ  formation of DNA-anti-DNA IC in the glomeruli was proposed, 
based  on  the  affinity of free  DNA  for  the  glomerular basement  membrane  (32). 
Indeed, anti-DNA antibodies were eluted from kidneys of mice injected with LPS. 
However, the anti-DNA antibodies represented only a fraction of the immunoglobu- 
lins deposited in the kidneys, suggesting that other IC were also involved (10). 
It has been observed that polyclonal B cell activation, experimentally induced by 
B cell mitogens or naturally occurring in the course of some autoimmune or infectious 
diseases, is often associated with the production of circulating IC (3, 5,  10,  11). This 
led to suggesting that a wide expression of the B cell repertoire, including rheumatoid 
factor-like antibodies and anti-idiotype autoantibodies, might generate IC formed by 
immunoglobulin interactions. Recently (14),  we were able to demonstrate the pro- 
duction of immunoglobulins bearing a known idiotype (T15 idiotype) of correspond- 
ing anti-idiotypic antibodies and of circulating T15 idiotype-anti-T15 idiotype IC in 
BALB/c  mice  injected  with  LPS  2 or  infected  with  trypanosomes.  Therefore,  we 
wondered whether such idiotype-anti-idiotype IC could be involved in the glomerular 
lesions observed in these mice (3,  10). In this report, evidence is provided that T15 
idiotype-anti-T 15 idiotype IC are deposited in the glomeruli of BALB/c mice injected 
with LPS. Renal deposition of both T 15 idiotype-bearing immunoglobulins and anti- 
T 15 idiotype autoantibodies was demonstrated by immunofluorescence studies, trace 
labeling experiments, and analysis of kidney eluates. 
In preliminary experiments, we confirmed the occurrence of both circulating and 
glomerular  IC  after  LPS  injection.  As  previously observed,  2 we  found  that  some 
circulating IC contained anti-T 15 idiotype antibodies. The presence of T15 idiotype- M. GOLDMAN, L. M. ROSE, A. HOCHMANN, AND P.  H. LAMBERT  1395 
anti-T15  idiotype  IC  in  the  renal  glomeruli  was  first  investigated  by  a  specific 
immunofluorescence method to detect T15 idiotypic sites.  Rabbit anti-T15 idiotype 
antibodies were found to react with molecules deposited in granular fashion in the 
glomeruli. As normal rabbit IgG did not show any similar reaction, this binding of 
anti-idiotypic antibodies is consistent with the presence of immunoglobulins bearing 
T15 idiotypic determinants within the glomerular IC. This is further supported by 
the inhibition of the glomerular staining observed when kidney sections were incu- 
bated with an excess of T 15 idiotype in addition to the rabbit anti-idiotypic antibodies. 
This  inhibition was  idiotype-specific because  it  was  observed  with TI5  idiotypic- 
positive IgM monoclonal antibody as well as with the TEPC-15  myeloma protein 
used to prepare  the rabbit  anti-idiotypic antibodies, but not with the MOPC-460 
myeloma protein, another IgA(K) that does not bear the T15 idiotype. The analysis 
of kidney eluates confirmed the renal deposition of immunoglobulins bearing T15 
idiotypic determinants. Indeed, radiolabeled eluates were found to react with rabbit 
anti-T15 idiotype antibodies but not with normal rabbit IgG. 
Evidence was also obtained that anti-T15 idiotype autoantibodies were deposited 
in  the kidneys of mice injected with  LPS.  First, radiolabeled  kidney eluates were 
found to react with the TEPC-15 myeloma protein, but not with a different IgA (K) 
myeloma protein (MOPC-460) nor with a different anti-PC antibody (HPC-16). The 
reaction of the eluates with the TEPC-15 myeloma protein was due to immunoglob- 
ulin molecules because it was eliminated by immunoadsorption on anti-mouse im- 
munoglobulin antibodies. These data strongly suggest that anti-T15  idiotype anti- 
bodies were present among the immunoglobulins eluted from the kidneys. Second, 
FITC-conjugated TEPC-15 myeloma protein was found to localize in the glomeruli 
after intravenous injection. This  in  vivo renal  binding was shown to  be  idiotype- 
specific and could be quantified in a  trace-labeling experiment, as compared with 
that of MOPC-167 myeloma protein, another PC-binding IgA (K). It is possible that 
the  injected  TEPC-15  myeloma  protein  combined  in  the  circulation  with  anti- 
idiotypic antibodies before renal deposition. However, the levels of circulating anti- 
T15 idiotype antibodies are quite low  18 d  after LPS injection,  2 and it seems more 
likely that the TEPC-15 myeloma protein reacted with anti-T15 idiotype antibodies 
already deposited in the glomeruli. 
We think that our observations indicate that after LPS injection in BALB/c mice 
(a) T15 idiotype-anti-T15 idiotype are deposited in the glomeruli, and (b) circulating 
immunoglobulins bearing T15 idiotypic determinants are then able to localize in the 
glomeruli by an idiotype-specific mechanism. The persistance in the kidneys of T15 
idiotype-bearing immunoglobulins up to 28 d  after LPS injection perhaps reflects a 
progressive accumulation of these molecules on T15  idiotype-anti-T15 idiotype IC 
already deposited in the glomeruli. Such in situ rearrangement of glomerular IC has 
been  reported  in  several  models,  where  it  was  also  thought  to  contribute  to  the 
perpetuation of IC in the glomeruli (33). 
The  formation  of idiotype-anti-idiotype  IC  after  polyelonal  B  cell  activation 
probably depends on a simultaneous production of idiotypes and corresponding anti- 
idiotypic antibodies. In these experiments, we demonstrated the occurrence of circu- 
lating and glomerular T15 idiotype-anti-T15 idiotype IC, whereas anti-MOPC-460 
idiotype and anti-MOPC-167 idiotype antibodies were not detected within IC. The 
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only a small proportion of the IC deposited in the kidneys, which can be estimated at 
4-5%. Other IC could involve autoantigens such as DNA (I0), but one can speculate 
that many other idiotypes than the T15 idiotype could participate in the formation 
of idiotype-anti-idiotype IC. Indeed, it is clear that a  variety of idiotypic clones are 
expressed during polyclonal B cell activation, and one can think that a  variety of 
anti-idiotypic clones are expressed as well (13). It would be logical that major idiotype- 
anti-idiotype interactions would mostly involve dominant idiotypes of the antibody 
repertoire. In addition, idiotype-anti-idiotype IC would only occur for those dominant 
idiotypes for which corresponding anti-idiotypic antibodies are simultaneously trig- 
gered.  This  hypothesis is  consistent  with  the  involvement  of the  T15  idiotype in 
idiotype-anti-idiotype IC.  This  idiotype is a  major idiotype of BALB/c mice (15), 
expressed on 60-70% of the anti-PC antibodies detected after LPS injection,  2 and we 
have demonstrated a simultaneous triggering of T 15 idiotypic clones and of anti-T t 5 
idiotypic clones during polyclonal B cell activation (14). 
Idiotypic interactions could be involved in the immunopathology of some human 
diseases.  Anti-gamma globulin antibodies have been demonstrated in cryoprecipitates 
and in kidney lesions of some patients with systemic lupus erythematosus (34). Recent 
reports  have suggested the participation  of anti-idiotypic antibodies  in  mixed cry- 
oglobulins (35) and the possible occurence of antibodies against idiotypic determinants 
of anti-DNA antibodies in systemic lupus erythematosus (36). Idiotype-anti-idiotype 
IC could be generated in such diseases and participate in the development of IC- 
mediated lesions. Idiotypic interactions could also play some role in diseases associated 
with repeated antigenic stimulations (16). The data presented in this paper suggest 
that idiotype-anti-idiotype IC could be involved in the pathogenesis of some glomer- 
ular diseases.  This would be consistent with the difficulty to identify specific antigens 
in  many glomerulonephritides  associated  with  immunoglobulin deposits  (4).  One 
should  consider  that  the  largest  source  of potential  antigens  and  corresponding 
antibodies probably exists within the B cell repertoire and that the formation of IC 
might often represent an exacerbation of physiological interactions within an idiotypic 
network. 
Summary 
We investigated the possible role of idiotypic interactions in the pathogenesis of the 
glomerular  lesions  observed  in  mice  undergoing  polyclonal  B  cell  activation. 
BALB/c mice were studied for the presence of renal deposits of T15  idiotype-anti- 
T15 idiotype-immune complexes (IC) after injection of bacterial lipopolysaecharides 
(LPS). The T 15 idiotype is the major idiotype of BALB/c mice anti-phosphorylcholine 
(PC) antibodies, which are cross-reactive with the idiotype of the TEPC-15 myeloma 
protein. This model was used because T15 idiotype-anti-T15 idiotype IC have been 
detected in the circulation of BALB/c mice after polyclonal B cell activation. First, 
an idiotype-specific immunofluorescence technique allowed us to detect T t5 idiotype- 
bearing immunoglobulins in  glomeruli  from day 6  to day 28  after LPS injection. 
Second, fluorescein isothiocyanate-conjugated TEPC-15 myeloma protein was found 
to localize in the glomeruli after in vivo injection 18 d after LPS administration. This 
renal  localization was shown to  be  idiotype-specific and could be  quantified in  a 
trace-labeling experiment. Third, kidney-deposited immunoglobulins of mice injected 
with LPS were eluted, radiolabeled, and analyzed by radioimmunoassay. Both T15 M.  GOLDMAN, L.  M.  ROSE,  A. HOCHMANN,  AND  P.  H.  LAMBERT  1397 
idiotype-bearing immunoglobulins and anti-T 15 idiotype antibodies were detected in 
the eluates, providing further evidence  for a  renal deposition of T15  idiotype-anti- 
T15 idiotype IC. 
Polyclonal B  cell activation is likely to result in a  simultaneous triggering of many 
idiotypic clones and of corresponding anti-idiotypic clones represented in the B  cell 
repertoire. This could lead to the formation of a  variety of idiotype-anti-idiotype IC 
that could participate in the development of glomerular lesions. 
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